Yıl: 2011 Cilt: 22 Sayı: 1 Sayfa Aralığı: 89 - 92 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma

Öz:
Epiteloid hemajioendotelioma, endotelial hücrelerden köken alan yumuşak doku malign tümörüdür. Klinik bulguları hemanjiomdan anjiosarkoma kadar değişir.Tedavi rejimi henüz net değildir. Rezeksiyon en sık önerilen yöntem olmasına rağmen, multinodüler olgularda transplantasyon sıklıkla uygulanmaktadır. Transplantasyon ve rezeksiyon haricindeki tedavi şekilleri etkili değildir ve anrezektabl epiteloid hemajioendotelioma olgularında ortanca yaşam süresi 8 aydır. Bu olguda, epiteloid hemajioendotelioma olgularında intrarateriyel radyonuklid Y-90 mikroküre tedavisinin etkinliği ve tedavi cevabının değerlendirmesinde F18 florodeoksiglukoz pozitron emisyon tomografi/bilgisayarlı tomografi'nin yeri değerlendirilmiştir.
Anahtar Kelime:

Konular: Cerrahi

Hemanjioendoteliomada intraarteriyel radyonüklid tedavi

Öz:
Epithelioid hemangioendothelioma is a malignant soft tissue tumor originating from the endothelial cell. Its clinical course varies from benign hemangioma to angiosarcoma. The therapy procedure remains unclear. Although resection of the tumor is the most frequently suggested treatment, due to its multinodular type, transplantation is frequently performed. Therapy regimens other than transplantation and resection are not effective and the median survival in hemangioendothelioma with unresectable lesions is approximately eight months. In this case, we report the therapeutic effect of selective intra-arterial radionuclide yttrium (Y)-90 microspheres and the value of F-18 fluorodeoxyglucose positron emission tomography/computed tomography to evaluate therapy response in hemangioendothelioma.
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • 1. Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 1982; 50: 970-81.
  • 2. Ishak KG, Sesterhemm IA, Goodman ZD, et al. Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow up study of 32 cases. Hum Pathol 1984; 15: 839-52.
  • 3. Uchimura K, Nakamuta M, Osoegawa M, et al. Hepatic epithelioid hemangioendothelioma. J Clin Gastroenterol 2001; 32: 431-4.
  • 4. Garcia-Botella A, Diez-Valladeres L, Martin-Antona E, et al. Epithelioid hemangioendothelioma of the liver. J Hepatobiliary Pancreat Surg 2006; 13: 167-71.
  • 5. Nguyen BD. Epithelioid hemangioendothelioma of liver with F-18 FDG PET imaging. Clin Nucl Med 2004; 29: 828-30.
  • 6. Suga K, Kawakami Y, Hiyama A, Hori K. F-18 FDG PET/CT monitoring of radiation therapeutic effect in hepatic epithelioid hemangioendothelioma. Clin Nucl Med 2009; 34: 199-202.
  • 7. Lin E, Agoff N. Recurrent hepatic epithelioid hemangioendothelioma detection by FDG PET/CT. Clin Nucl Med 2007; 32: 949-51.
  • 8. Salcedo M, Alvarez E, Clemente G, et al. Epithelioid hemangioendothelioma: a rare indication for liver transplantation? Gastroenterol Hepatol 1995; 18: 22-6.
  • 9. Nagase M, Ryu M, Kinoshito T, et al. Epithelioid hemangioendothelioma of the liver. J Hepatobiliary Pancreat Surg 2000; 7: 443-7.
  • 10. Kayler LK, Merion RM, Arenas JD, et al. Epithelioid endothelioma of the liver disseminated to the peritoneum treated with liver transplantation and interferon alpha 2B. Transplantation 2002; 74: 128-30.
  • 11. Gelin M, Van de Stadt J, Rickaert F, et al. Epithelioid hemangioendothelioma of the liver following contact with vinyl chloride. Recurrence after orthotopic transplantation. J Hepat 1989; 8: 99-106.
  • 12. Mulcahy MF, Lewandowski RJ, Ibrahim SM, et al. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer 2009; 115: 1849-58.
  • 13. Lewandowski RJ, Kulik LM, Riaz A, et al. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 2009; 9: 1920-8.
APA LAÇİN S, KÜÇÜK N, ÖZ İ, bilgic s (2011). Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma. , 89 - 92.
Chicago LAÇİN Seda,KÜÇÜK NURİYE ÖZLEM,ÖZ İbrahim İlker,bilgic sadık Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma. (2011): 89 - 92.
MLA LAÇİN Seda,KÜÇÜK NURİYE ÖZLEM,ÖZ İbrahim İlker,bilgic sadık Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma. , 2011, ss.89 - 92.
AMA LAÇİN S,KÜÇÜK N,ÖZ İ,bilgic s Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma. . 2011; 89 - 92.
Vancouver LAÇİN S,KÜÇÜK N,ÖZ İ,bilgic s Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma. . 2011; 89 - 92.
IEEE LAÇİN S,KÜÇÜK N,ÖZ İ,bilgic s "Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma." , ss.89 - 92, 2011.
ISNAD LAÇİN, Seda vd. "Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma". (2011), 89-92.
APA LAÇİN S, KÜÇÜK N, ÖZ İ, bilgic s (2011). Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma. Turkish Journal of Gastroenterology, 22(1), 89 - 92.
Chicago LAÇİN Seda,KÜÇÜK NURİYE ÖZLEM,ÖZ İbrahim İlker,bilgic sadık Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma. Turkish Journal of Gastroenterology 22, no.1 (2011): 89 - 92.
MLA LAÇİN Seda,KÜÇÜK NURİYE ÖZLEM,ÖZ İbrahim İlker,bilgic sadık Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma. Turkish Journal of Gastroenterology, vol.22, no.1, 2011, ss.89 - 92.
AMA LAÇİN S,KÜÇÜK N,ÖZ İ,bilgic s Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma. Turkish Journal of Gastroenterology. 2011; 22(1): 89 - 92.
Vancouver LAÇİN S,KÜÇÜK N,ÖZ İ,bilgic s Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma. Turkish Journal of Gastroenterology. 2011; 22(1): 89 - 92.
IEEE LAÇİN S,KÜÇÜK N,ÖZ İ,bilgic s "Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma." Turkish Journal of Gastroenterology, 22, ss.89 - 92, 2011.
ISNAD LAÇİN, Seda vd. "Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma". Turkish Journal of Gastroenterology 22/1 (2011), 89-92.